This subtype involves two or more TP53 mutations or one TP53 mutation with evidence of copy number loss or copy-neutral loss of heterozygosity (cnLOH) at the TP53 locus, correlating with a poor prognosis due to a high likelihood of transformation to AML [274]. The gene discussed is TP53; the disease is acute myeloid leukemia.